Cell-Based Therapy for Cerebral Palsy: A Puzzle in Progress.

Area of Science:

• Regenerative Medicine
• Neuroscience
• Pediatric Neurology

Background:

• Cell-based therapy is a promising avenue for treating cerebral palsy (CP).
• Current therapeutic protocols lack standardization regarding cell source, dosage, timing, and administration routes.
• This necessitates research to define optimal parameters for effective CP treatment.

Purpose of the Study:

• To compare the efficacy of two distinct cell types for CP treatment.
• To analyze trends in Gross Motor Function Measure-66 (GMFM-66) scores following cell therapy.
• To provide insights for refining cell-based therapeutic protocols for CP.

Main Methods:

• Intrathecal injection of umbilical cord blood mononuclear cells (UCB-MNCs).
• Intrathecal injection of umbilical cord tissue mesenchymal stromal cells (UCTMSCs).
• Assessment of changes in GMFM-66 scores in pediatric CP patients.

Main Results:

• UCB-MNC injections demonstrated earlier improvements in gross motor function.
• UCTMSC applications resulted in more sustained improvements in gross motor function.
• Comparative analysis highlights differential effects of cell types on motor function recovery.

Conclusions:

• Different cell types yield distinct therapeutic outcomes in CP.
• UCB-MNCs may be suitable for rapid functional gains.
• UCTMSCs show potential for long-term functional stability in CP patients.